Octreotide long-acting release in the treatment of autosomal dominant polycystic kidney disease: a meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-01-21
DOI
https://doi.org/10.3389/fendo.2025.1709818
Primary Topic
Genetic and Kidney Cyst Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Octreotide long-acting release in the treatment of autosomal dominant polycystic kidney disease: a meta-analysis

Mengyan Jin, Ping Shi, Yang Yu
Frontiers in Endocrinology
Genetic and Kidney Cyst Diseases
article

Octreotide long-acting release in the treatment of autosomal dominant polycystic kidney disease: a meta-analysis

Mengyan Jin, Ping Shi, Yang Yu
article en

Abstract

No abstract available for this paper.
Frontiers in EndocrinologyVol. 16
Sichuan University (CN), West China Hospital of Sichuan University (CN), Qujiang People's Hospital (CN)
Sichuan University, West China Hospital, Sichuan University
Good health and well-being
Openalex Percentile: Top 77%
Genetic and Kidney Cyst Diseases
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Octreotide long-acting release in the treatment of autosomal dominant polycystic kidney disease: a meta-analysis — Mengyan Jin, Ping Shi, et al. · Frontiers in Endocrinology (2026) | TGRS Research Map | TGRS